|
Market Closed -
NYSE
01:30:02 04/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 164.77 USD | +1.94% |
|
+0.15% | +79.23% |
| 03/09 | UK stocks rise as bond rally lifts risk sentiment | RE |
| 03/09 | AstraZeneca Kept at Buy as Berenberg Notes Upcoming COPD Data Readout | MT |
| Market Cap | 26TCr 22TCr 21TCr 19TCr 35TCr 24,10700Cr 35TCr 2,43600Cr 95TCr 12,32000Cr 96TCr 94TCr 39,67700Cr | P/E 2026 * |
21.2x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 27TCr 24TCr 22TCr 20TCr 38TCr 25,94700Cr 38TCr 2,62200Cr 1,02100Cr 13,26000Cr 1,03100Cr 1,00800Cr 42,70500Cr | EV / Sales 2026 * |
4.34x | EV / Sales 2027 * | 3.99x |
| Free-Float |
96.63% | Yield 2026 * |
2.03% | Yield 2027 * | 2.17% |
Last Transcript : AstraZeneca PLC
| 1 day | +1.94% | ||
| Current month | +77.61% | ||
| Current year | +79.23% |
| Current year | 89.04 |  | 165.74 |
| 1 year | 72.9 | | 165.74 |
| 3 years | 60.47 | | 165.74 |
| 5 years | 52.65 | | 165.74 |
| 10 years | 25.55 | | 165.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.94% | +0.15% | - | - | 26TCr | |
| -0.04% | -1.40% | +57.16% | +108.15% | 1,03400Cr | |
| +1.17% | +4.76% | +56.42% | +73.50% | 67TCr | |
| -0.58% | +0.80% | +22.82% | +75.58% | 46TCr | |
| +0.41% | -0.31% | +29.71% | +38.79% | 35TCr | |
| -0.49% | +5.33% | +25.42% | +46.40% | 31TCr | |
| +0.40% | +1.42% | -0.39% | +13.56% | 26TCr | |
| +0.29% | +1.63% | +56.46% | +73.00% | 24TCr | |
| +0.67% | +2.77% | -15.76% | -53.66% | 21TCr | |
| +1.08% | +1.59% | +33.83% | +97.29% | 19TCr | |
| Average | +0.44% | +1.27% | +29.52% | +52.51% | 41.3TCr | |
| Weighted average by Cap. | +0.23% | +1.04% | +38.29% | +67.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.32TCr 5.44TCr 5.11TCr 4.67TCr 8.72TCr 5,97800Cr 8.79TCr 60TCr 24TCr 3,05500Cr 24TCr 23TCr 9,83900Cr | 6.68TCr 5.75TCr 5.4TCr 4.94TCr 9.22TCr 6,31800Cr 9.29TCr 64TCr 25TCr 3,22900Cr 25TCr 25TCr 10,39900Cr |
| Net income | 1.2TCr 1.03TCr 969.88Cr 887.36Cr 1.66TCr 1,13600Cr 1.67TCr 11TCr 4.47TCr 58TCr 4.51TCr 4.41TCr 1,86900Cr | 1.37TCr 1.18TCr 1.11TCr 1.01TCr 1.89TCr 1,29400Cr 1.9TCr 13TCr 5.09TCr 66TCr 5.14TCr 5.03TCr 2,13000Cr |
| Net Debt | 1.95TCr 1.67TCr 1.57TCr 1.44TCr 2.68TCr 1,84000Cr 2.7TCr 19TCr 7.24TCr 94TCr 7.31TCr 7.15TCr 3,02800Cr | 1.18TCr 1.01TCr 951.81Cr 870.83Cr 1.63TCr 1,11400Cr 1.64TCr 11TCr 4.38TCr 57TCr 4.43TCr 4.33TCr 1,83400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | $164.77 | +1.94% | 24,25,271 |
| 02/26/02 | $161.63 | -0.52% | 33,01,432 |
| 01/26/01 | $162.47 | +0.21% | 25,98,488 |
| 31/26/31 | $162.13 | -0.35% | 30,68,214 |
| 28/26/28 | $162.70 | -1.11% | 28,80,829 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
